Fax +41 61 306 12 34
E-Mail karger@karger.ch
www.karger.com
Original Paper
Pharmacology 2008;81:110–117
DOI: 10.1159/000110011
Nebivolol Induces a Hyperpolarizing Effect on
Smooth Muscle Cells in the Mouse Renal Artery by
Activation of Beta-2-Adrenoceptors
A. Georgescu
a
F. Pluteanu
a
M.-L. Flonta
a
E. Badila
b
M. Dorobantu
b
D. Popov
a
a
University of Bucharest, Faculty of Biology, and
b
Emergency Hospital Bucharest, Institute of Cellular Biology and
Pathology ‘N. Simionescu’, Bucharest, Romania
denuded renal arteries. The results of this study show that
nebivolol exerts vasodilator effects on the SMC in the de-
nuded renal arteries and the maximal response is achieved
at a concentration of 50 mol/l. Nebivolol effects involve
binding to the
2
-adrenoceptors and the subsequent activa-
tion of Ca
2+
-activated K
+
channels in SMC, with no contribu-
tion of NO. Taken together, the study brings new insights
into the mechanism underlying the nebivolol-induced arte-
rial vasodilation. Copyright © 2008 S. Karger AG, Basel
Introduction
In physiological conditions, the renal artery plays a
very important role in the control of the blood pressure
[1]. In pathological conditions such as hypertension and
diabetes (rats), vasodilation of the renal microcirculation
is impaired [2]. In these cases, cardiovascular drugs may
have beneficial effects, and these could be manifested at
the level of endothelium and vascular smooth muscle
cells. Nebivolol, a new selective
1
-adrenoceptor-block-
ing agent with vasodilator properties, was suggested as
beneficial in hypertension [3, 4] . The D-enantiomer has
the
1
-blocking properties, whereas the L-enantiomer in-
duces vasodilatation via
2
-adrenoceptor binding, with a
Key Words
Renal artery Nebivolol Vasodilation Hyperpolarization
Abstract
Nebivolol is a highly selective
1
-adrenoceptor antagonist
with vasodilator properties involving the vascular endothe-
lium, but its effect on the smooth muscle cells (SMC) is still
unclear. In this paper, we tested the effect of nebivolol on
renal artery smooth muscle cells and investigated the cellu-
lar mechanism involved. To this purpose, the denuded renal
arteries isolated from mice were studied in vitro using the
myograph and the nitric oxide (NO) sensor techniques, while
the SMC in culture were analyzed by the patch-clamp tech-
nique. The myograph technique was used to assay the vaso-
dilator effect of nebivolol on the arterial muscular layer, and
to establish the optimal dose of the drug to be tested on
single SMC by the patch-clamp technique. Using both the
myograph and the patch-clamp techniques, we examined
the potential contribution of
2
-adrenoceptors and Ca
2+
-ac-
tivated K
+
channels to the nebivolol-induced effects, by ex-
posing the denuded arteries and SMC cultures to specific
inhibitors such as butoxamine (100 mol/l), tetraethylam-
monium (TEA, 1 mmol/l), and iberiotoxin (100 nmol/l). The
direct measurement of NO using the NO sensor enabled us
to evaluate if nebivolol induces/or not the release of NO in
Received: June 12, 2007
Accepted: June 12, 2007
Published online: October 19, 2007
Adriana Georgescu, PhD
Institute of Cellular Biology and Pathology ‘Nicolae Simionescu’
8, BP Hasdeu Street, PO Box 35-14
RO–050568 Bucharest (Romania)
Tel. +40 1 319 4518, Fax +40 1 319 4519, E-Mail adriana.georgescu@ icbp.ro
© 2008 S. Karger AG, Basel
0031–7012/08/0812–0110$24.50/0
Accessible online at:
www.karger.com/pha